Almirall Continues Its Positive Trajectory in Q1 2026 in Line With Expectations – Led by 19.3% YoY Growth of Its European Dermatology Business

Go back to Almirall Continues Its Positive Trajectory in Q1 2026 in Line With Expectations – Led by 19.3% YoY Growth of Its European Dermatology Business
Alabama Power Co. 5.875% Sr. Notes Series 2007B (NASDAQ: ALM) Delayed: 18.19 -0.47 (2.52%)
Previous Close $18.66    52 Week High $27.10 
Open $17.50    52 Week Low $24.10 
Day High $18.81    P/E N/A 
Day Low $17.10    EPS $0.00 
Volume 3,302,579